Results 231 to 240 of about 105,303 (279)
Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy
ABSTRACT Recently, immune checkpoint inhibitors (ICIs), particularly PD‐1/PD‐L1 and CTLA‐4 inhibitors, have revolutionized cancer treatment, significantly improving survival rates for various malignancies. However, ICI therapies targeting single checkpoints on T cells still face numerous challenges, such as low response rates and post‐treatment ...
Yangyang Li, Zizhen Kang, Yanyun Du
wiley +1 more source
Improving Outcomes in Chronic Graft-vs-Host Disease. [PDF]
Mitchell SA, Cowen EW.
europepmc +1 more source
Graft-vs-Host Disease After Liver Transplantation: A Diagnostic and Management Challenge. [PDF]
Chin JY, Gong J, Gane E.
europepmc +1 more source
ABSTRACT Tumor organoid models are revolutionizing cancer research by bridging the translational gap between conventional two‐dimensional cell cultures and animal models. This Editorial thoroughly explores the fundamental innovations of patient‐derived organoid technology.
Yimao Wu +4 more
wiley +1 more source
Xenogeneic humoral Graft-Vs-Host disease following Hamster-to-Rat bone marrow transplantation
Toshio Miki +8 more
openalex +2 more sources
A multifunctional electrospun scaffold combining polyurethane, carbon nanotubes, and liposomal hesperidin supports neural stem cell survival, adhesion, and expansion. This platform enhances conductivity, mechanical strength, and hydrophilicity while mimicking the native neural environment.
Arman Abroumand Gholami +8 more
wiley +1 more source
“It's just us”: Families' experiences with temporary tube feeding
Abstract Background Children with temporary feeding tubes are discharged home with increasing frequency, yet little is known about how families adapt and manage in their home environment. Whereas the physical side effects of temporary feeding tubes are well documented, the psychosocial impact on families remains underresearched. Understanding families'
Claire Reilly +4 more
wiley +1 more source
Editorial: Cellular Therapies: Past, Present and Future
Ralf Dressel +3 more
doaj +1 more source

